Endeavour Sil (EXK) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 40-F for FY2025, filed Mar 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EXK SEC filings page.
Endeavour Sil (EXK) reported $467.5M in revenue for fiscal year 2025, up 114.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Rapid production expansion is consuming heavy capital, with growth funded substantially through external financing rather than internally generated cash.
In FY2025, the company paired a$119.1M net loss with$67.4M of operating cash flow, indicating that noncash charges and working-capital movements materially separate reported earnings from cash generation. Yet free cash flow remained negative at-$101.8M because capital expenditures reached$169.2M , so accounting cash conversion does not currently cover reinvestment.
Revenue more than doubled to
Total assets expanded to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Endeavour Sil's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Endeavour Sil, and counted as zero in the overall score.
Endeavour Sil's revenue surged 114.8% year-over-year to $467.5M, reflecting rapid business expansion. This strong growth earns a score of 95/100.
Endeavour Sil carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.
Endeavour Sil's current ratio of 1.53 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.
While Endeavour Sil generated $67.4M in operating cash flow, capex of $169.2M consumed most of it, leaving -$101.8M in free cash flow. This results in a low score of 6/100, reflecting heavy capital investment rather than weak cash generation.
Not available for Endeavour Sil, and counted as zero in the overall score.
Endeavour Sil passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Endeavour Sil reported a net loss of $119.1M while generating $67.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Endeavour Sil held $215.4M in cash against $12.7M in long-term debt as of Q4 2025, with $276.8M of liabilities due within a year.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
EXK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
EXK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2540-F | Q4'2440-F | Q4'2310-K | Q4'2210-K | Q4'2110-K | Q4'2010-K | Q4'1910-K | Q4'1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.2B+71.8% | $719.2M+51.5% | $474.8M+18.9% | $399.4M+35.9% | $294.0M+39.6% | $210.6M+28.6% | $163.7M-7.5% | $177.0M-0.9% |
| Current Assets | $423.2M+168.5% | $157.6M+56.4% | $100.8M-31.1% | $146.3M-9.5% | $161.8M+54.1% | $105.0M+65.9% | $63.3M-18.9% | $78.0M-11.9% |
| Cash & Equivalents | $215.4M+102.4% | $106.4M+201.5% | $35.3M-57.7% | $83.4M-19.3% | $103.3M+69.1% | $61.1M+161.4% | $23.4M-30.0% | $33.4M-12.8% |
| Inventory | $62.3M+73.1% | $36.0M+32.1% | $27.3M+42.1% | $19.2M-30.2% | $27.5M+65.2% | $16.6M+22.5% | $13.6M-8.8% | $14.9M+13.4% |
| Accounts Receivable | $26.0M+400.0% | $5.2M-76.7% | $22.3M+57.6% | $14.1M-2.3% | $14.5M-28.2% | $20.1M+8.5% | $18.6M-31.1% | $26.9M-20.8% |
| Goodwill | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| Total Liabilities | $656.6M+179.6% | $234.8M+165.4% | $88.5M+5.9% | $83.5M+47.6% | $56.6M+9.9% | $51.5M+25.9% | $40.9M+26.8% | $32.3M+0.6% |
| Current Liabilities | $276.8M+250.8% | $78.9M+35.5% | $58.2M+10.4% | $52.7M+30.1% | $40.6M+17.4% | $34.6M+39.1% | $24.8M+5.6% | $23.5M+5.7% |
| Non-Current Liabilities | $379.8M+143.6% | $155.9M+415.8% | $30.2M-1.9% | $30.8M+91.7% | $16.1M-5.3% | $17.0M+5.5% | $16.1M+83.8% | $8.7M-10.8% |
| Long-Term Debt | $12.7M-89.6% | $122.6M+21221.7% | $575K-29.2% | $812K+2.3% | $794K-13.8% | $921K-14.2% | $1.1M | N/A |
| Total Equity | $579.1M+19.5% | $484.4M+25.4% | $386.3M+22.3% | $315.9M+33.1% | $237.4M+49.2% | $159.1M+29.5% | $122.8M-15.2% | $144.8M-1.2% |
| Retained Earnings | -$491.3M-32.0% | -$372.2M-9.2% | -$340.9M+2.1% | -$348.1M+1.8% | -$354.3M+3.8% | -$368.3M+0.7% | -$370.9M-14.5% | -$324.0M-3.5% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
EXK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
EXK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Endeavour Sil EXK | FY2025 | $467.5M | -$119.1M | -25.5% | $3.3B | 38/100 |
| Silvercorp Metal SVM | FY2025 | $298.9M | $78.8M | 26.4% | $2.8B | 60/100 |
| Mag Silver MAG | FY2024 | N/A | $77.8M | N/A | $2.5B | — |
| First Majestic AG | FY2025 | $1.3B | $211.0M | 16.8% | $10.3B | 58/100 |
| Centerra Gold CGAU | FY2023 | $1.1B | -$81.3M | -7.4% | $4.5B | — |
| Ero Copper ERO | FY2025 | $785.8M | $266.9M | 34.0% | $3.6B | 35/100 |
Where Endeavour Sil Ranks
Frequently Asked Questions
What is Endeavour Sil's annual revenue?
Endeavour Sil (EXK) reported $467.5M in total revenue for fiscal year 2025. This represents a 114.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Endeavour Sil's revenue growing?
Endeavour Sil (EXK) revenue grew by 114.8% year-over-year, from $217.6M to $467.5M in fiscal year 2025.
Is Endeavour Sil profitable?
No, Endeavour Sil (EXK) reported a net income of -$119.1M in fiscal year 2025, with a net profit margin of -25.5%.
How much debt does Endeavour Sil have?
As of fiscal year 2025, Endeavour Sil (EXK) had $215.4M in cash and equivalents against $12.7M in long-term debt.
What is Endeavour Sil's net profit margin?
Endeavour Sil (EXK) had a net profit margin of -25.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Endeavour Sil's return on equity (ROE)?
Endeavour Sil (EXK) has a return on equity of -20.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Endeavour Sil's free cash flow?
Endeavour Sil (EXK) recorded an outflow of $101.8M in free cash flow during fiscal year 2025. This represents a 42.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Endeavour Sil's operating cash flow?
Endeavour Sil (EXK) generated $67.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Endeavour Sil's total assets?
Endeavour Sil (EXK) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Endeavour Sil's capital expenditures?
Endeavour Sil (EXK) invested $169.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Endeavour Sil's current ratio?
Endeavour Sil (EXK) had a current ratio of 1.53 as of fiscal year 2025, which is generally considered healthy.
What is Endeavour Sil's debt-to-equity ratio?
Endeavour Sil (EXK) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Endeavour Sil's return on assets (ROA)?
Endeavour Sil (EXK) had a return on assets of -9.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Endeavour Sil's P/E ratio?
Endeavour Sil (EXK) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $3.3B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Endeavour Sil's price-to-sales ratio?
Endeavour Sil (EXK) trades at 7.0x sales, its market capitalization divided by revenue of $467.5M revenue, FY2025. The market capitalization is $3.3B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Endeavour Sil's Piotroski F-Score?
Endeavour Sil (EXK) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Endeavour Sil's earnings high quality?
Endeavour Sil (EXK) reported a net loss of $119.1M while generating $67.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Endeavour Sil?
Endeavour Sil (EXK) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.